Dr Reddy’s launches Bosutinib Tablets 400mg, a generic of Bosulif, in the US with MSN Laboratories, holds exclusive US marketing rights, shares down 0.24 percent FridayRead More
Dr Reddy’s launches cancer drug Bosutinib used for treatment of Chronic Myeloid Leukaemia
- by stefan